genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Cholesterol-Ferrying Proteins Promote Buildup of Cardiovascular Plaque
News
Rapid, AI-Powered Genetic Disease Diagnosis for Critically Ill Infants
News
Gene Regulation Finding Advances Understanding of Neurodevelopmental Disorders
News
Obesity and Diabetes Risk Linked to Common Food Ingredient
News
Kite to Build Manufacturing Site in Maryland’s Frederick County
Insights
Insights
Wacker Biotech Bullish on Microbial Biomanufacturing
Neuroscience
Straight from the Brain, So to Speak
Insights
Urine-Based Liquid Biopsy for Nonurological Cancers
Insights
Top 10 Best-Selling Cancer Drugs of 2018
GWAS
Genetic Basis of Obesity Carries Weight
A-Lists
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
Insights
Top 10 Immuno-Oncology Collaborations
A-Lists
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Cholesterol-Ferrying Proteins Promote Buildup of Cardiovascular Plaque
News
Obesity and Diabetes Risk Linked to Common Food Ingredient
Insights
Wacker Biotech Bullish on Microbial Biomanufacturing
News
Kite to Build Manufacturing Site in Maryland’s Frederick County
Magazine
April 2019 Vol. 39 No. 4
Functional Ultrasound
Commentary
Linear DNA Crosses the Line between Tags and Therapeutics
April 2019 Vol. 39 No. 4
Nucleic Acid Extraction: Extremely Fast, Extremely Simple, Extremely Effective
April 2019 Vol. 39 No. 4
CRISPR and Beyond: Advances in Gene Therapy
April 2019 Vol. 39 No. 4
Epigenetic Therapies Return Cells to the Straight and Narrow
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Upcoming Webinars
How to Decrease Long Read Sequencing Sample QC Time by 10-Fold
Videos
The First Computer-Generated Bacterial Genome
April 2019 Vol. 39 No. 4
Functional Ultrasound
Upcoming Webinars
De-Risky Business: Assessing Biotherapeutic Off-Target and On-Target Liabilities
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Hematologic Conditions
Hematologic Conditions
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Hematologic Conditions
After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial of Xencor Blood Cancer Antibody XmAb14045
Hematologic Conditions
AMAG Pharmaceuticals to Acquire Perosphere Pharmaceuticals
Hematologic Conditions
Harbour BioMed to Develop Kelun-Biotech’s Cancer Immunotherapy Candidate A167
Hematologic Conditions
Reversible Technique Developed for Stem Cell Expansion
Hematologic Conditions
Curcumin Shown to Inhibit DYRK2 and Reduce Cancer Burden
Hematologic Conditions
CRISPR Improves Red Blood Cell Transfusion Success
Hematologic Conditions
Model Wound System Created that Self Heals
Hematologic Conditions
Shire Hemophilia Candidate Using Xenetic Platform Falls Short in Trial
Hematologic Conditions
Nohla and UC Davis Ink Manufacturing Deal for Off-the-Shelf Donor Stem...
Hematologic Conditions
Novartis Acquires Selexys Pharmaceuticals
Hematologic Conditions
Takeda to Co-Develop Gencia’s MAGR Drugs in Up-to-$500M+ Partnership
Hematologic Conditions
Blood-Cleansing Biospleen Developed
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Synthetic biologists at the University of Bristol have succeeded in generating laboratory-made red blood cells with rare blood group types. [Dr. Ashley Toye/University of Bristol]](https://www.genengnews.com/wp-content/uploads/2018/08/Apr30_2018_UnivBristol_GeneEditedRedBloodCells1901781571-324x160.jpg "CRISPR Improves Red Blood Cell Transfusion Success")
